Comparative pathobiology of macaque lymphocryptoviruses

Comparative Medicine

Volumn 58, Issue 1, 2008, Pages 57-67

  Carville, Angela ^a   Mansfield, Keith G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; B LYMPHOCYTE; CARCINOGENESIS; COMPARATIVE STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HERPES VIRUS; HERPES VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IN SITU HYBRIDIZATION; INFECTIOUS MONONUCLEOSIS; LEUKOPLAKIA; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; MACACA; MYCOSIS FUNGOIDES; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY; VIRUS INFECTION; VIRUS TRANSMISSION;

ANIMALS; BURKITT LYMPHOMA; DNA, VIRAL; GAMMAHERPESVIRINAE; GENOME, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCRYPTOVIRUS; LYMPHOCYTES; MACACA; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR VIRUS INFECTIONS;

EID: 40949104399     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Ablashi DV, Loeb WF, Pearson G, Valerio MG, Armstrong GR, Rabin H, Kingsbury EW, Heine U. 1973. Induction of lymphoma in owl monkeys with heated, noncytopathogenic Herpesvirus saimiri. Nat New Biol 242:28-30.
2. Adams A, Lindahl T. 1975. Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci USA 72:1477-1481.
3. Andersson J. 2006. Epstein-Barr virus and Hodgkin's lymphoma. Herpes 13:12-16.
4. Andersson J. 2000. An overview of Epstein-Barr virus: from discovery to future directions for treatment and prevention. Herpes 7:76-82.
5. Avgil M, Ornoy A. 2006. Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection. Reprod Toxicol 21:436-445.
6. Barahona H, Melendez LV, Hunt RD, Daniel MD. 1976. The owl monkey (Aotus trivirgatus) as an animal model for viral diseases and oncologic studies. Lab Anim Sci 26:1104-1112.
7. Baskin GB, Cremer KJ, Levy LS. 2001. Comparative pathobiology of HIV- and SIV-associated lymphoma. AIDS Res Hum Retroviruses 17:745-751.
8. Baskin GB, Roberts ED, Kuebler D, Martin LN, Blauw B, Heeney J, Zurcher C. 1995. Squamous epithelial proliferative lesions associated with rhesus Epstein-Barr virus in simian immunodeficiency virus-infected rhesus monkeys. J Infect Dis 172:535-539.
9. Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W. 2001. Expression of the simian Epstein-Barr virus-encoded latent membrane protein 1 in malignant lymphomas of SIV-infected rhesus macaques. J Med Virol 65:114-120.
10. Borisch-Chappuis B, Nezelof C, Muller H, Muller-Hermelink HK. 1990. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. Am J Pathol 136:751-758.
11. Bouvier G, Hergenhahn M, Polack A, Bornkamm GW, de The G, Bartsch H. 1995. Characterization of macromolecular lignins as Epstein-Barr virus inducer in foodstuff associated with nasopharyngeal carcinoma risk. Carcinogenesis 16:1879-1885.
12. Calderwood MA, Venkatesan K, Xing L, Chase MR, Vazquez A, Holthaus AM, Ewence AE, Li N, Hirozane-Kishikawa T, Hill DE, Vidal M, Kieff E, Johannsen E. 2007. Epstein-Barr virus and virus human protein interaction maps. Proc Natl Acad Sci USA 104:7606-7611.
13. Cho YG, Gordadze AV, Ling PD, Wang F. 1999. Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus. J Virol 73:9206-9212.
14. Coates HL, Pearson GR, Neel HB 3rd, Weiland LH. 1978. Epstein-Barr virus-associated antigens in nasopharyngeal carcinoma. Arch Otolaryngol 104:427-430.
15. Cook RC, Connors JM, Gascoyne RD, Fradet G, Levy RD. 1999. Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation. Lancet 354:1698-1699.
16. Elazary AS, Wolf DG, Amir G, Avni B, Rund D, Yehuda DB, Sviri S. 2007. Severe Epstein-Barr virus-associated hemophagocytic syndrome in six adult patients. J Clin Virol 40:156-159.
17. Eliopoulos AG, Dawson CW, Mosialos G, Floettmann JE, Rowe M, Armitage RJ, Dawson J, Zapata JM, Kerr DJ, Wakelam MJ, Reed JC, Kieff E, Young LS. 1996. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMPl: involvement of TRAF3 as a common mediator. Oncogene 13:2243-2254.
18. Elstrom RL, Andreadis C, Aqui NA, Ahya VN, Bloom RD, Brozena SC, Olthoff KM, Schuster SJ, Nasta SD, Stadtmauer EA, Tsai DE. 2006. Treatment of PTLD with rituximab or chemotherapy. Am J Transplant 6:569-576.
19. Epstein MA, Achong BG, Barr YM. 1964. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 283:702-703.
20. Ferrari MG, Rivadeneira ED, Jarrett R, Steveeva L, Takemoto S, Markham P, Franchini G. 2001. HV(MNE), a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits. Blood 98:2193-2199.
21. Fogg MH, Carville A, Cameron J, Quink C, Wang F. 2005. Reduced prevalence of Epstein-Barr virus-related lymphocryptovirus infection in sera from a New World primate. J Virol 79:10069-10072.
22. Fogg MH, Garry D, Awad A, Wang F, Kaur A. 2006. The BZLF1 homolog of an Epstein-Barr-related gammaherpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques. J Immunol 176:3391-3401.
23. Fogg MH, Kaur A, Cho YG, Wang F. 2005. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA1 homologue. J Virol 79:12681-12691.
24. Fortgang IS, Srivastav SK, Baskin GB, Schumacher PM, Levy LS. 2004. Retrospective analysis of clinical and laboratory factors associated with lymphoma in simian AIDS. Leuk Lymphoma 45:161-169.
25. Gaffey MJ, Frierson HF Jr, Medeiros LJ, Weiss LM. 1993. The relationship of Epstein-Barr virus to infection-related (sporadic) and familial hemophagocytic syndrome and secondary (lymphoma-related) hemophagocytosis: an in situ hybridization study. Hum Pathol 24:657-667.
26. Gaidano G, Lo Coco F, Ye BH, Shibata D, Levine AM, Knowles DM, Dalla-Favera R. 1994. Rearrangements of the BCL6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood 84:397-402.
27. Gandhi MK. 2006. Epstein-Barr virus-associated lymphomas. Expert Rev Anti Infect Ther 4:77-89.
28. Gerner CS, Dolan A, McGeoch DJ. 2004. Phylogenetic relationships in the Lymphocryptovirus genus of the Gammaherpesvirinae. Virus Res 99:187-192.
29. Habis A, Baskin G, Simpson L, Fortgang I, Murphey-Corb M, Levy LS. 2000. Rhesus lymphocryptovirus infection during the progression of SAIDS and SAIDS-associated lymphoma in the rhesus macaque. AIDS Res Hum Retroviruses 16:163-171.
30. Harrington DS, Weisenburger DD, Purtilo DT. 1987. Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer 59:1419-1429.
31. Hemenway CG. 1989. Hairy leukoplakia, EBV: an oral history of AIDS. Dent Today 8:18-19, 50.
32. Henle W, Henle G. 1974. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma. Ann Clin Lab Sci 4:109-114.
33. Henle W, Henle G. 1970. Evidence for a relation of Epstein-Barr virus to Burkitt's lymphoma and nasopharyngeal carcinoma. Bibl Haematol 36:706-713.
34. Hislop AD, Ressing ME, van Leeuwen D, Pudney VA, Horst D, Koppers-Lalic D, Croft NP, Neefjes JJ, Rickinson AB, Wiertz EJ. 2007. A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J Exp Med 204:1863-1873.
35. Hislop AD, Taylor GS, Sauce D, Rickinson AB. 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25:587-617.
36. Huang DP, Ho JH, Henle W, Henle G. 1974. Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies. Int J Cancer 14:580-588.
37. Jenson HB, Ench Y, Zhang Y, Gao SJ, Arrand JR, Mackett M. 2002. Characterization of an Epstein-Barr virus-related gammaherpesvirus from common marmoset (Callithrix jacchus). J Gen Virol 83:1621-1633.
38. Jiang H, Cho YG, Wang F. 2000. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus. J Virol 74:5921-5932.
39. Johnson DR, Wolfe LG, Levan G, Klein G, Ernberg I, Aman P. 1983. Epstein-Barr virus (EBV)-induced lymphoproliferative disease in cotton-topped marmosets. Int J Cancer 31:91-97.
40. Kahnt K, Matz-Rensing K, Hofmann P, Stahl-Hennig C, Kaup FJ. 2002. SIV-associated lymphomas in rhesus monkeys (Macaca mulatto) in comparison with HIV-associated lymphomas. Vet Pathol 39:42-55.
41. Kikuta H, Osato T, Matsumoto S. 1989. Sites of Epstein-Barr virus replication in acute and chronic active Epstein-Barr virus infections. Intervirology 30:346-350.
42. Klein E, Teramoto N, Gogolak P, Nagy N, Bjorkholm M. 1999. LMP1, the Epstein-Barr virus-encoded oncogene with a B cell activating mechanism similar to CD40. Immunol Lett 68:147-154.
43. Klein G. 1986. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors. AIDS Res 2 Suppl 1:S167-S176.
44. Klein G. 1982. Epstein-Barr virus, malaria, and Burkitt's lymphoma. Scand J Infect Dis Suppl 36:15-23.
45. Krause J. 2005. AIDS-related non-Hodgkin's lymphomas. Microsc Res Tech 68:168-175.
46. Kutok JL, Klumpp S, Simon M, MacKey JJ, Nguyen V, Middeldorp JM, Aster JC, Wang F. 2004. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques. J Virol 78:3455-3461.
47. Labandeira J, Peteiro C, Toribio J. 1994. Hairy leucoplakia and HIV2 - a case report and review of the literature. Clin Exp Dermatol 19:335-340.
48. Leib DA, Hart CA, McCarthy K. 1987. Characterization of four herpesviruses isolated from owl monkeys and their comparison with Herpesvirus saimiri type 1 (Herpesvirus tamarinus) and herpes simplex virus type 1. J Comp Pathol 97:159-169.
49. Leight ER, Sugden B. 2000. EBNA1: a protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol 10:83-100.
50. Lennette ET, Winberg G, Yadav M, Enblad G, Klein G. 1995. Antibodies to LMP2A/2B in EBV-carrying malignancies. Eur J Cancer 31:1875-1878.
51. Li Q, Turk SM, Hutt-Fletcher LM. 1995. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol 69:3987-3994.
52. Lim WH, Russ GR, Coates PT. 2006. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology (Carlton) 11:355-366.
53. Loeb WF, Valerio MG, Ablashi DV, Armstrong GR. 1973. Lymphoma induction and viral isolation from owl monkey (Aotus trivirgatus) inoculated with lymphoma cells induced by Herpesvirus saimiri. Am J Vet Res 34:677-680.
54. McClain KL. 2001. Epstein-Barr virus and HIV-AIDS-associated diseases. Biomed Pharmacother 55:348-352.
55. Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L. 2007. Lytic cycle switches of oncogenic human gammaherpesviruses. Adv Cancer Res 97:81-109.
56. Moghaddam A, Koch J, Annis B, Wang F. 1998. Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus. J Virol 72:3205-3212.
57. Moghaddam A, Rosenzweig M, Lee-Parritz D, Annis B, Johnson RP, Wang F. 1997. An animal model for acute and persistent Epstein-Barr virus infection. Science 276:2030-2033.
58. Mueller GA, Pickoff AS. 2003. Pediatric lymphocytic interstitial pneumonitis in an HIV-negative child with pulmonary Epstein-Barr virus infection. Pediatr Pulmonol 36:447-449.
59. Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dorken B, Riess H, Gartner B. 2006. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Ann Hematol 85:478-484.
60. Oertel SH, Verschuuren E, Reinke P, Zeidler K, Papp-Vary M, Babel N, Trappe RU, Jonas S, Hummel M, Anagnostopoulos I, Dorken B, Riess HB. 2005. Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant 5:2901-2906.
61. Ohga S, Nomura A, Takada H, Hara T. 2002. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol 44:203-215.
62. Peng R, Gordadze AV, Fuentes Panana EM, Wang F, Zong J, Hayward GS, Tan J, Ling PD. 2000. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses. J Virol 74:379-389.
63. Pingel S, Hannig H, Matz-Rensing K, Kaup FJ, Hunsmann G, Bodemer W. 1997. Detection of Epstein-Barr virus small RNAs EBER1 and EBER2 in lymphomas of SIV-infected rhesus monkeys by in situ hybridization. Int J Cancer 72:160-165.
64. Prang NS, Hornef MW, Jager M, Wagner HJ, Wolf H, Schwarzmann FM. 1997. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89:1665-1677.
65. Raab-Traub N. 2002. Epstein-Barr virus in the pathogenesis of NPC Semin Cancer Biol 12:431-441.
66. Rajcani J, Kudelova M. 2003. Gamma herpesviruses: pathogenesis of infection and cell signaling. Folia Microbiol (Praha) 48:291-318.
67. Ramer JC, Garber RL, Steele KE, Boyson JF, O'Rourke C, Thomson JA. 2000. Fatal lymphoproliferative disease associated with a novel gammaherpesvirus in a captive population of common marmosets. Comp Med 50:59-68.
68. Rangan SR, Martin LN, Bozelka BE, Wang N, Gormus BJ. 1986. Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma. Int J Cancer 38:425-432.
69. Rao P, Jiang H, Wang F. 2000. Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections. J Clin Microbiol 38:3219-3225.
70. Rivadeneira ED, Ferrari MG, Jarrett RF, Armstrong AA, Markham P, Birkebak T, Takemoto S, Johnson-Delaney C, Pecon-Slattery J, Clark EA, Franchini G. 1999. A novel Epstein-Barr virus-like virus, HV(MNE), in a Macaca nemestrina with mycosis fungoides. Blood 94:2090-2101.
71. Rivailler P, Carville A, Kaur A, Rao P, Quink C, Kutok JL, Westmoreland S, Klumpp S, Simon M, Aster JC, Wang F. 2004. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Blood 104:1482-1489.
72. Rivailler P, Cho YG, Wang F. 2002. Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a New World primate: a defining point in the evolution of oncogenic lymphocryptoviruses. J Virol 76:12055-12068.
73. Rivailler P, Jiang H, Cho YG, Quink C, Wang F. 2002. Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model. J Virol 76:421-426.
74. Rivailler P, Quink C, Wang F. 1999. Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus. J Virol 73:8867-8872.
75. Roizmann B, Desrosiers RC, Fleckenstein B, Lopez C, Minson AC, Studdert MJ. 1992. The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol 123:425-449.
76. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. 1992. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66:122-131.
77. Ruff KR, Puetter A, Levy LS. 2007. Growth regulation of simian and human AIDS-related non-Hodgkin's lymphoma cell lines by TGF-β1 and IL6. BMC Cancer 7:35.
78. Sandvej K, Krenacs L, Hamilton-Dutoit SJ, Rindum JL, Pindborg JJ, Pallesen G. 1992. Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia. Histopathology 20:387-395.
79. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the coreceptor SLAM. Nature 395:462-469.
80. Schmidtko J, Wang R, Wu CL, Mauiyyedi S, Harris NL, Della Pelle P, Brousaides N, Zagachin L, Ferry JA, Wang F, Kawai T, Sachs DH, Cosimi BA, Colvin RB. 2002. Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys. Transplantation 73:1431-1439.
81. Schmidt-Westhausen A, Gelderblom HR, Reichart PA. 1990. Oral hairy leukoplakia in an HIV-seronegative heart transplant patient. J Oral Pathol Med 19:192-194.
82. Sebelin-Wulf K, Nguyen TD, Oertel S, Papp-Vary M, Trappe RU, Schulzki A, Pezzutto A, Riess H, Subklewe M. 2007. Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. Transpl Immunol 17:203-210.
83. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ. 2006. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci USA 103:7065-7070.
84. Spina M, Tirelli U, Zagonel V, Gloghini A, Volpe R, Babare R, Abbruzzese L, Talamini R, Vaccher E, Carbone A. 1998. Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients. Cancer 82:766-774.
85. Strauss M. 1972. Burkitt's lymphoma, nasopharyngeal carcinoma, infectious mononucleosis and the Epstein-Barr virus. Laryngoscope 82:2049-2058.
86. Su IJ, Wang CH, Cheng AL, Chen RL. 1995. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma 19:401-406.
87. Suzuki J, Goto S, Kato A, Hashimoto C, Miwa N, Takao S, Ishida T, Fukuoka A, Nakayama H, Doi K, Isowa K. 2005. Malignant NK/T-cell lymphoma associated with simian Epstein-Barr virus infection in a Japanese macaque (Macaca fuscata). Exp Anim 54:101-105.
88. Taylor AL, Marcus R, Bradley JA. 2005. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 56:155-167.
89. Tsurumi T, Fujita M, Kudoh A. 2005. Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15:3-15.
90. Urquiza M, Suarez J, Lopez R, Vega E, Patino H, Garcia J, Patarroyo MA, Guzman F, Patarroyo ME. 2004. Identifying gp85-regions involved in Epstein-Barr virus binding to B lymphocytes. Biochem Biophys Res Commun 319:221-229.
91. Vetsika EK, Callan M. 2004. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med 6:1-16.
92. Wang F, Rivailler P, Rao P, Cho Y. 2001. Simian homologues of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356:489-497.
93. Westmoreland SV, Mansfield KG. 2008. Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhabdinoviruses. Comp Med 58:31-42.
94. Wright DH. 1999. What is Burkitt's lymphoma and when is it endemic? Blood 93:758.
95. Wu L, Hutt-Fletcher LM. 2007. Compatibility of the gH homologues of Epstein-Barr virus and related lymphocryptoviruses. J Gen Virol 88:2129-2136.
96. Wu Y, Maruo S, Yajima M, Kanda T, Takada K. 2007. EBER2 but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. J Virol [Forthcoming].
97. Xu D, Brumm K, Zhang L. 2006. The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production. J Biol Chem 281:9163-9169.
98. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757-768.